Monsanto (MON -0.4%) signs a deal with Alnylam Pharmaceuticals (ALNY +3.6%) to use the...

|About: Monsanto Company (MON)|By:, SA News Editor

Monsanto (MON -0.4%) signs a deal with Alnylam Pharmaceuticals (ALNY +3.6%) to use the biopharma's gene-silencing technology to improve its biopesticides. MON gains exclusive rights to use ALNY's platform technology and intellectual property; ALNY will receive $29M in upfront payments plus milestone payments and research funding.